SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended December 2021 remained nearly unchanged at Rs. 20330.54 millions.Net profit stood at Rs. 5485.19  millions  compared to Rs. 4423.25 millions in the corresponding previous quarter,high by 24.01%.OP of the company witnessed a marginal growth to 7272.25 millions from 6113.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 20330.54 19724.78 3.07 63560.37 57175.65 11.17 75679.33 67126.31 12.74
Other Income 2167.43 811.27 167.17 4356.47 2793.80 55.93 3962.37 6067.88 -34.70
PBIDT 7272.25 6113.63 18.95 19622.83 18137.15 8.19 22865.78 19110.18 19.65
Interest 497.72 830.41 -40.06 1620.32 2033.91 -20.33 2658.98 2563.90 3.71
PBDT 6774.53 5742.24 17.98 22305.84 16842.16 32.44 20945.72 16731.82 25.18
Depreciation 407.98 412.12 -1.00 1179.23 1138.15 3.61 1508.15 1385.38 8.86
PBT 6366.55 5330.12 19.44 21126.61 15704.01 34.53 19437.57 15346.44 26.66
TAX 881.36 906.87 -2.81 3204.69 2627.25 21.98 2943.10 1800.96 63.42
Deferred Tax -525.12 -25.16 1987.12 -503.44 -119.64 320.80 -493.08 -891.41 -44.69
PAT 5485.19 4423.25 24.01 17921.92 13076.76 37.05 16494.47 13545.48 21.77
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 35.77 30.99 15.41 30.87 31.72 -2.68 30.21 28.47 6.13

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×